Human gastric carcinoma transduced with theIL-2 gene: Increased sensitivity to immune effector cellsin vitro andin vivo
Open Access
- 3 July 1997
- journal article
- Published by Wiley in International Journal of Cancer
- Vol. 72 (1) , 174-183
- https://doi.org/10.1002/(sici)1097-0215(19970703)72:1<174::aid-ijc25>3.0.co;2-i
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Intratumoral injection of an adenovirus expressing interleukin 2 induces regression and immunity in a murine breast cancer model.Proceedings of the National Academy of Sciences, 1995
- Transduction of Human Melanoma Cells with Interleukin-2 Gene Reduces Tumorigenicity and Enhances Host Antitumor Immunity: A Nude Mouse Model1Cellular Immunology, 1994
- Functional interleukin-2 receptors on intestinal epithelial cells.Journal of Clinical Investigation, 1993
- Prospective Randomized Trial of High-Dose Interleukin-2 Alone or in Conjunction With Lymphokine-Activated Killer Cells for the Treatment of Patients With Advanced CancerJNCI Journal of the National Cancer Institute, 1993
- Interleukin-2 and interleukin-2 receptor expression in human corticotrophic adenoma and murine pituitary cell cultures.Journal of Clinical Investigation, 1992
- Expression of the interleukin-2 receptor on human fibroblasts and its biological significanceInternational Immunology, 1992
- The JAM test A simple assay for DNA fragmentation and cell deathJournal of Immunological Methods, 1991
- Interleukin 2 gene transfer into tumor cells abrogates tumorigenicity and induces protective immunity.The Journal of Experimental Medicine, 1990
- Local administration of cells containing an inserted IL-2 gene and producing IL-2 inhibits growth of human tumours in nu/nu miceImmunology Letters, 1988
- T cell growth factor receptors. Quantitation, specificity, and biological relevanceThe Journal of Experimental Medicine, 1981